Lv1
60 积分 2026-02-25 加入
Reversal of tumor immunosuppression and induction of potent antitumor immunity via albumin-based co-delivery of paclitaxel and a PD-L1 inhibitor
1个月前
已采纳
Artificial intelligence in peptide-based drug design
1个月前
已采纳
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial
1个月前
已采纳
皖公网安备34019202002308
